For the supply of Pulmicort Turbohaler 400
key details
| Value | £1,083,000 |
|---|---|
| Status | cancelled |
| Category (CPV) | 33600000 |
| Deadline | 30 Mar 2021 |
| Contract start | 1 Apr 2021 |
| Contract end | 31 Mar 2022 |
| Procedure | limited |
| SME suitable | No |
| OCID | ocds-b5fd17-1c73f9ad-52be-4095-9c61-956d5338e25d |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| *DUPLICATE* ASTRAZENECA UK LIMITED | £1,083,000 | 23 Feb 2022 | active |
description
The Department of Health and Social Care conducted a Direct Award under the Regulation 32(2)(b)(iii) of the Public Contracts Regulations 2015 (as amended) for the supply of Pulmicort Turbohaler 400 mg. The contract period expires on 31 March 2022.
documents
- https://www.contractsfinder.service.gov.uk/Notice/753c47d6-add4-4de0-b706-a0a2dbd64a6f , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/4d70a849-ab01-4ef9-bffb-9657987ae8d0
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 6 Jan 2023 | Tender cancelled (tenderCancellation) | · | 753c47d6-add4-4de0-b706-a0a2dbd64a6f-603695 |
| 25 Jan 2023 | Award (award) | · | c74a16c2-f1c9-4364-8356-ede72b82e5f8-608588 |
more from Department of Health and Social Care (DHSC)
- Hugh's Report-MH Impact of Life-threatening Child Illness on families 2026 · £216,540 · 26 Jun 2026
- D&B + API Interface · £542,011 · 25 Jun 2026
- NCMP IT System - Discovery Phase · £183,768 · 19 May 2026
- DHSC: CL Temporary Executive Support to the Permanent Secretary - JW · £17,702 · 19 May 2026
- DHSC: GO: 26/27 - WIST: DAC hosting on CSP · £168,000 · 2 Apr 2026
- RM1043.8-1-DEPARTMENT OF HEALTH AND SOCIAL CARE - Find Public Health Data · £1,251,360 · 2 Apr 2026
- DHSC:NHST: National GP Engagement on Health Data · £267,000 · 31 Mar 2026
- DHSC: CL FGO Contingent Labour SD Extension · £133,710 · 31 Mar 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.